Promotions & Moves

Almac Discovery Appoints BD VP

Dr. Alan Lamont will be responsible for all commercial activities within the Discovery group

Almac Discovery, a member of the Almac Group, has appointed Dr. Alan Lamont as vice president of business development and licensing, reporting to managing director and president, Dr. Stephen Barr. 
 
Dr. Lamont be responsible for all commercial activities within Discovery including the evaluation, structuring, negotiation and due diligence of business development and licensing opportunities, and providing commercial input into research and discovery strategy as part of the Discovery senior management team.
 
Dr. Lamont is an experienced executive with more than 30 years employed in both pharmaceutical and biotech environments throughout the UK and U.S. He has held senior global roles including Executive Director, Global External R&D with Eli Lilly and, most recently, Senior BD Lead at Mundipharma International.
 
Combining a scientific background and qualification with strong business development and licensing experience, he is experienced in drug discovery, development and technology platforms. 
 
Dr. Barr, said, “We are pleased to welcome Alan to our senior management team at Almac Discovery.  With extensive experience in the pharma and biotech space, particularly within the BD and licensing space, his expertise, understanding and industry insight makes him the ideal choice to oversee this vital function.  We very much look forward to working with him as we continue to expand globally.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters